Szela Mary T. - 18 Feb 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Sean Murphy, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
18 Feb 2025
Net transactions value
$0
Form type
4
Filing time
19 Feb 2025, 17:41:47 UTC
Previous filing
31 Jan 2025
Next filing
06 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +21,089 +4.7% $0.000000 465,348 18 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on such vesting date.